{"disease":{"id":"postpartum-hypertension","name":"Postpartum hypertension","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:31:21.551Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":0,"pipeline_drug_count":1,"trial_count":0},"drugs":{"marketed":[],"pipeline":[{"drug_id":"torsemide","indication_name":"Postpartum hypertension","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"TORSEMIDE","company_name":"","drug_phase":"marketed","molecular_target":"Na+/K+/2Cl- carrier system","drug_class":"Loop Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":"Torsemide inhibits the Na+/K+/2Cl- carrier system in the thick ascending limb of the loop of Henle, leading to increased excretion of sodium, chloride, and water."}],"offLabel":[],"totalMarketed":0,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT02468310","title":"Evaluating the Effects of SMS Text Messaging Support System Among Frontline Health Workers in Ghana","phase":"NA","overall_status":"COMPLETED","enrollment_count":65831,"lead_sponsor_name":"Hannah Brown Amoakoh","has_results":false},{"nct_id":"NCT03298802","title":"Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":612,"lead_sponsor_name":"The University of Texas Medical Branch, Galveston","has_results":false},{"nct_id":"NCT05309460","title":"Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Nebraska Methodist Health System","has_results":false},{"nct_id":"NCT05009433","title":"HIIT vs MICT During Pregnancy and Health and Birth Outcomes in Mothers and Children","phase":"NA","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Gdansk University of Physical Education and Sport","has_results":false},{"nct_id":"NCT07204756","title":"HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT05849103","title":"Comprehensive Postpartum Management for Women With Hypertensive Disorders of Pregnancy","phase":"NA","overall_status":"COMPLETED","enrollment_count":343,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":true},{"nct_id":"NCT04835233","title":"Management of Hypertension in the Early Postpartum: a Randomized Controlled Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Federal University of Paraíba","has_results":false},{"nct_id":"NCT06915792","title":"PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":110,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT07486375","title":"Self-Management App for Blood Pressure and Well-Being in Postpartum Women With Hypertensive Disorders of Pregnancy","phase":"NA","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"National Cheng-Kung University Hospital","has_results":false},{"nct_id":"NCT06500351","title":"Renalase(rs10887800) Genotyping & Leucocytes Telomere Length in Postpartum. Hypertension","phase":"","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT04914819","title":"Postpartum Weight Loss for Women at Elevated Cardiovascular Risk","phase":"NA","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"University of Pennsylvania","has_results":true},{"nct_id":"NCT04752475","title":"Lasix for the Prevention of De Novo Postpartum Hypertension","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"Columbia University","has_results":true}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}